Nature Communications (Mar 2023)
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells
Abstract
G protein-coupled receptors are a major class of drug targets. Here, the authors develop a method whereby their biophysical and functional properties can be altered through directed evolution in mammalian cells, leading to variants exhibiting features such as high stability and expression, or increased allosteric coupling.